AppOnboard App Store Demos are Unlocking Explosive Growth of Apps and Games in Emerging Markets via Google Play Instant
Today AppOnboard, a mobile app demo technology and analytics platform for developers, has announced that AppOnboard’s App Store Demos have experienced wide global adoption since launching in late August, especially in emerging markets. App Store Demos allow users to demo apps and games directly on the Google Play Store without a download, via Google Play Instant.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181018005368/en/
AppOnboard's App Store Demo for FoxNext Games' MARVEL Strike Force (Photo: Business Wire)
"AppOnboard and its technology has been one of the driving factors for this growth,” said Google’s Ben Frenkel. “Many developers have leveraged App Store Demos to enable their Google Play Instant apps quickly and without needing to dedicate their own engineering resources."
Today, Google holds its annual Google Playtime event in Berlin and San Francisco, where top developers from around the world gather to discuss the latest features and best practices for Android and Google Play.
“The appetite for the ‘Try Now’ button on Google Play rivals anything I have seen in mobile since the launch of mobile app stores,” said Jonathan Zweig, CEO of AppOnboard.
India and Brazil have been particularly big consumers of App Store Demos to-date. With many international countries lacking comprehensive 3G/4G coverage and WiFi options, Google’s “Try Now” button is becoming the default user behavior for experiencing apps in these countries. Previously, apps and games would have to be downloaded in their entirety before they could be tried or demoed.
“App Store Demos, and the Google Play Instant product, are perfect solutions for users in emerging markets,” said Bryan Buskas, COO AppOnboard. “These Instant Apps unlock previously inaccessible content and put them at the fingertips of every consumer.”
Since launching with its initial set of partners in August, including Jam City, Scopely, Huuuge Games, and Simple Habit, AppOnboard has since helped more global developers activate their “Try Now” buttons quickly and effectively. Superheart Studios recently leveraged an App Store Demo to gauge Android interest for its 3D aquarium game, Ocean Reef Life, and has driven 10,000 daily pre-registrations. Two other worldwide developers, FoxNext Games and Game Insight, were able to showcase their 3D games, MARVEL Strike Force and Guns of Boom, as Google Play Instant apps through the use of AppOnboard technology.
“Getting new users to convert from curious to installed has always been the industry's biggest challenge,” said Anatoly Ropotov, CEO at Game Insight. “By partnering with AppOnboard to build our Google Play Instant app, we were able to give potential players a taste of what Guns of Boom has to offer through an instant demo that faithfully reflects the game."
MARVEL Strike Force, a hit Mobile Squad Based Superhero game from FoxNext, partnered with AppOnboard to enable its “Try Now” button at the end of September. The game is currently the #2 Top Grossing app on the Google Play Store and has amassed 5 million downloads to-date.
“The Google Play Instant program is great because it prequalifies players and lets them try a game to see if it is up their alley,” said Sebastian Kriese, Vice President, Platform Relations at FoxNext Games. “We at FoxNext Games were impressed by the 3D quality our App Store Demo was able to achieve, and we launched our ‘Try Now’ button much faster thanks to the help of AppOnboard.”
App Store Demos leverage AppOnboard’s playable demo engine, optimized creative, and user behavior analytics and help developers launch their Google Play Instant apps quickly and effectively. In addition to giving users the ability to demo the app or game on the storefront, developers are also driving higher quality users by launching App Store Demos. Those users who engage with an App Store Demo prior to installing have shown higher retention (+32% D1, +29% D7) and have been more likely to become paying users (+44% D1, +37% D7) when compared to users who install right away.
For more information on AppOnboard or to claim your 30-day free trial of App Store Demos, please visit: play.apponboard.com.
About AppOnboard:
AppOnboard is a mobile app demo and analytics platform that powers Full-Fidelity Demos, which allow users to instantly experience an app or game without downloading it. AppOnboard enables app and game testing as well as product insights and optimization for developers. Founded in 2016 and headquartered in Los Angeles with offices in San Francisco and Seattle, AppOnboard is venture-backed by Korea Investment Partners (KIP), Mirae Asset Management, Mantaray, MTG, Ophir Capital Group, Runa Capital, Troy Capital Partners, 500 Startups and London Venture Partners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181018005368/en/
Contact information
AppOnboard
Bryan Buskas, 1-424-293-2501
contact@apponboard.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom